2nd Circ. Axes Challenge To Medicare Drug Price Negotiations
By Brian Steele · August 7, 2025, 4:37 PM EDT
In a published opinion Thursday, the Second Circuit turned away Boehringer Ingelheim's constitutional and administrative challenge to the Medicare Drug Price Negotiation Program, finding that the program is voluntary and it...
To view the full article, register now.